FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to purulent surgery, and can be used for treating patients with critical ischemia of lower extremities. For this purpose, standard medical therapy is additionally combined with single-step wound layered infiltration of soft tissues by Perftoran at 3 cm from wound edges in dose 10-15 ml if the wound is localised on a feet, and 40-50 ml if the wound is localised on a leg or a hip every second day in amount 8-10 procedures.
EFFECT: method allows reducing length of treatment and managing pain syndrome, accelerating wound cleansing and healing in higher intensity of repair processes ensured by constant maximally effective active Perftoran concentration in the wound zone.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD TO TREAT DIABETIC ANGIOPATHY | 1997 |
|
RU2107496C1 |
METHOD FOR TREATING PURULENT-NECROTIC LESIONS OF THE FEET IN PATIENTS WITH ISCHEMIC FORM OF DIABETIC FOOT SYNDROME | 2022 |
|
RU2805258C1 |
METHOD FOR DETERMINING THE RISK OF DEVELOPMENT OF PURULENT-NECROTIC COMPLICATIONS OF THE AMPUTATION STUMP OF THE THIGH | 2022 |
|
RU2796306C1 |
METHOD OF FORECASTING CLINICAL OUTCOMES IN PATIENTS WITH CRITICAL ISCHEMIA OF LOWER EXTREMITIES | 2006 |
|
RU2323680C1 |
METHOD FOR TREATING CRITICAL ISCHEMIA OF LOWER EXTREMITIES | 2005 |
|
RU2289396C1 |
METHOD OF EARLY PRECLINICAL PREDICTION OF WOUND ABSCESS AFTER SECONDARY SURGICAL TREATMENT OF PUS INFECTION CENTERS | 2019 |
|
RU2733696C1 |
METHOD FOR SURGICAL MANAGEMENT OF DIABETIC OSTEOARTHROPATHY ACCOMPANIED BY TOTAL LOSS OF EXTREMITY SUPPORT ABILITY CAUSED BY SUPPURATIVE COMPLICATIONS | 2014 |
|
RU2561285C1 |
METHOD FOR TREATING ISCHEMIC FORM OF DIABETIC FOOT SYNDROME ALONG WITH DISTAL TYPE OF LESION IN ARTERIES OF INFERIOR LIMBS | 2005 |
|
RU2308945C2 |
METHOD OF LIMB OPEN FRACTURE TREATMENT | 2006 |
|
RU2327447C1 |
METHOD FOR SURGICAL TACTICS SELECTION DURING DIABETIC FOOT TREATMENT | 2016 |
|
RU2621945C1 |
Authors
Dates
2011-12-20—Published
2010-06-28—Filed